Related references
Note: Only part of the references are listed.Pharmacokinetic Interactions between Primaquine and Chloroquine
Sasithon Pukrittayakamee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Cell Wall Perturbation Sensitizes Fungi to the Antimalarial Drug Chloroquine
Farida Islahudin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Chloroquine sensitizes biofilms of Candida albicans to antifungal azoles
Ravikumar Bapurao Shinde et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Invasive candidiasis in intensive care units in China: a multicentre prospective observational study
Fengmei Guo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
An in vitro repositioning study reveals antifungal potential of chloroquine to inhibit growth and morphogenesis in Candida albicans
Ravikumar B. Shinde et al.
JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY (2013)
Antifungal Activity of Geldanamycin Alone or in Combination with Fluconazole Against Candida species
Jinqing Zhang et al.
MYCOPATHOLOGIA (2013)
Model System to Define Pharmacokinetic Requirements for Antimalarial Drug Efficacy
Rahul P. Bakshi et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
In vitro antifungal susceptibility of filamentous fungi causing rare infections: synergy testing of amphotericin B, posaconazole and anidulafungin in pairs
Maria Drogari-Apiranthitou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Pharmacokinetics, Pharmacodynamics, and Allometric Scaling of Chloroquine in a Murine Malaria Model
Brioni R. Moore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Candida bloodstream infections in intensive care units: Analysis of the extended prevalence of infection in intensive care unit study
Daniel H. Kett et al.
CRITICAL CARE MEDICINE (2011)
Emerging opportunistic yeast infections
Marisa H. Miceli et al.
LANCET INFECTIOUS DISEASES (2011)
Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy
Matteo Bassetti et al.
PLOS ONE (2011)
Mechanism of the Synergistic Effect of Amiodarone and Fluconazole in Candida albicans
Soledad Gamarra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry
David L. Horn et al.
CLINICAL INFECTIOUS DISEASES (2009)
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006)
Olivier Leroy et al.
CRITICAL CARE MEDICINE (2009)
Untitled - Preface
[Anonymous]
CURRENT MEDICAL RESEARCH AND OPINION (2009)
Determinants of mortality in non-neutropenic ICU patients with candidaemia
Deborah J. E. Marriott et al.
CRITICAL CARE (2009)
Fungal adaptation to the mammalian host: it is a new world, after all
Nicole M. Cooney et al.
CURRENT OPINION IN MICROBIOLOGY (2008)
Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome
Marie-Elisabeth Bougnoux et al.
INTENSIVE CARE MEDICINE (2008)
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Jean-Marc Rolain et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Chloroquine is therapeutic in murine experimental model of paracoccidioidomycosis
Luciane Alarcao Dias-Melicio et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)
Unexpected link between iron and drug resistance of Candida spp.:: Iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells
Tulika Prasad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts
M Ruhnke
CURRENT DRUG TARGETS (2006)
Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole
H Quan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Identification of medically important yeast species by sequence analysis of the internal transcribed spacer regions
SN Leaw et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2006)
Mechanisms of azole resistance in a clinical isolate of Candida tropicalis
P Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Regulatory networks affected by iron availability in Candida albicans
CY Lan et al.
MOLECULAR MICROBIOLOGY (2004)
PKSP-dependent reduction of phagolysosome fusion and intracellular kill of Aspergillus fumigatus conidia by human monocyte-derived macrophages
B Jahn et al.
CELLULAR MICROBIOLOGY (2002)
Resistance of Candida species to antifungal agents:: molecular mechanisms and clinical consequences
D Sanglard et al.
LANCET INFECTIOUS DISEASES (2002)
Comparison of Etest, chequerboard dilution and time-kill studies for the detection of synergy or antagonism between antifungal agents tested against Candida species
RE Lewis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Relationship between chloroquine toxicity and iron acquisition in Saccharomyces cerevisiae
LR Emerson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Rationale for combination antifungal therapy
RE Lewis et al.
PHARMACOTHERAPY (2001)
Share Paper
